Fresenius SE & Co. KGaA (FRE) - Stock & Dividends

Exchange: XETRA Stock Exchange • Country: Germany • Currency: EUR • Type: Common Stock • ISIN: DE0005785604

Fresenius SE & Co. KGaA, listed on XETRA as FRE, is a healthcare company specializing in products and services for dialysis, hospital care, and outpatient medical treatment. The company operates through four main segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed.

Fresenius Medical Care focuses on providing solutions for patients suffering from chronic kidney failure. They offer dialyzers, hemodialysis machines, and related disposable products, along with various dialysis-related services.

The Fresenius Kabi segment concentrates on the treatment and support of critically and chronically ill patients. They provide I.V. generic drugs, biosimilar drugs for autoimmune diseases and oncology, enteral and parenteral nutrition products, medical technologies, disposables, infusions pumps, apheresis machines, cell therapy devices, and other related products.

Fresenius Helios delivers clinical and nursing care services across different facilities, while Fresenius Vamed caters to hospitals and healthcare institutions by offering operational management and patient services. The company, established in 1912, was initially known as Fresenius SE before rebranding to Fresenius SE & Co. KGaA in January 2011. Headquartered in Bad Homburg vor der Höhe, Germany, Fresenius SE & Co. KGaA continues to be a leader in the healthcare industry. More information can be found on their website:

AI improved, may contain errors or wrong assumptions

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Fresenius SE & Co. KGaA (FRE) - Stock & Dividends

FRE Stock Overview

Market Cap in USD 15,987m
Sector Healthcare
Industry Medical Care Facilities
GiC SubIndustry Health Care Facilities
TER 0.00%
IPO / Inception

FRE Stock Ratings

Fundamental 2.92
Dividend 6.45
Growth 5y -3.13
Rel. Performance vs Sector -1.83
Analysts -
Fair Price Total Ret. 23.14
Fair Price DCF 141.37

FRE Dividends

Yield 12m 3.53%
Yield on Cost 5y 2.16%
Dividends CAGR 5y 2.87%
Payout Consistency 92.5%

FRE Growth Ratios

Growth 12m 9.18%
Growth Correlation 12m 29%
Growth Correlation 3m -63%
CAGR 5y -9.22%
CAGR / Mean Drawdown -0.35
Sharpe Ratio 12m 0.15
Alpha vs SP500 12m -16.80
Beta vs SP500 5y weekly 0.84
CAPM 7.56%
Average Daily Range 2m 2.40%
Regime Oscillator 44.56
Volatility GJR Garch 1y 25.31%
Price / SMA 50 -3.16%
Price / SMA 200 -4.22%
Current Volume 963.9k
Average Volume 20d 1138.3k

External Links for FRE Stock

X (Twitter)Stocktwits
Fund Manager Positions
What is the price of FRE stocks?
As of February 28, 2024, the stock is trading at EUR 26.08 with a total of 963,868 shares traded.
Over the past week, the price has changed by +0.15%, over one month by -3.23%, over three months by -7.52% and over the past year by +1.42%.
Why is FRE stock down?
Check with which Index or Commodity FRE has the highest Correlation, do they have a common driver?
Review the Fundamentals to find weaknesses (Debt, low returns). Check the Performance of the Peer-Group to find out, if the entire sector is under pressure.
Period Return FRE Return S&P 500
1 Month -3.23% 4.00%
3 Months -7.52% 11.99%
12 Months 1.42% 29.39%
What is the forecast for FRE stock price target?
According to ValueRays Forecast Model, FRE Fresenius SE & Co. KGaA will be worth about 25 in February 2025. The stock is currently trading at 26.08. This means that the stock has a potential downside of -4.18%.
Issuer Forecast Upside
Wallstreet Target Price 37.2 42.6%
Analysts Target Price - -
ValueRay Target Price 25 -4.2%